Update on the management of vascular patients with COVID-19

Attention has to be payed to patients with vascular disease (VD) cardiovascular risk factors (VD-CVR) and COVID-19. In fact, COVID-19 is also manifested with hypercoagulability, pulmonary intravascular coagulation, microangiopathy, and venous thromboembolism (VTE) or arterial thrombosis and VP are a frail population. Predisposing risk factors to severe COVID-19 are male sex, underlying cardiovascular disease, or cardiovascular risk factors including non-controlled diabetes mellitus or arterial hypertension, obesity, and advanced age. The VAS-European Independent Foundation in Angiology/Vascular Medicine has recently published an integral strategy for the management of patients with VD or cardiovascular risk factors (VD-CVR) and COVID-19. This paper represents a short summary.